Living organisms are constantly exposed to a variety of naturally occurring and man-made chemical (1997) 
Introduction
Many hazardous environmental agents exert by these genotoxins consists of single-and their toxic effects on humans and other double-strand breaks, modified bases and organisms by inducing modifications to the phosphate groups, and interstrand and genome; included among these agents are intrastrand cross-links, among others (1, 2) . numerous natural and man-made chemical When these alterations remain in the compounds as well as several types of double helix, replication can be blocked or radiation. The damage produced in DNA impeded, mutations to the genome can result when replication does occur, and gene expression can be compromised due to improper transcription, potentially leading to cellular transformation or death (2, 3) . It is critical that such damage be removed to ensure fidelity during DNA synthesis and to enable the cell to continue appropriate RNA synthesis.
Broadly defined, DNA repair refers to the collected pathways in a cell that assist in maintaining genomic integrity by removing inappropriate bases and other possible deleterious lesions from DNA. Numerous mechanisms have evolved to this end: a) nucleotide excision repair (NER) (2, (4) (5) (6) , b) base excision repair (BER) (2, 7, 8) , c) mismatch repair (MMR) (2, 9) , and d) direct reversal of the damage, in which no incision is made in the backbone of the DNA (2, 10, 11) . Overlap among these pathways exists in terms of the types of damage removed by each.
An important component of the DNA repair process that is involved in clearing the genome of damage is transcriptioncoupled DNA repair (TCR). This phenomenon is characterized by more rapid removal of certain modified bases from the transcribed strand of actively expressed genes when compared to silent DNA (3, 12, 13) . It has been proposed that TCR might exist to ensure that transcription can readily continue following a genotoxic assault, thus providing a means for producing transcripts essential for continued cell survival (3) . A corollary to this notion is that lesions in DNA that block or inhibit the progression of RNA polymerases are precisely those that are subject to TCR (3, 13) . Hence, the process of transcription is linked to DNA damage in that it can influence the clearance rate of certain lesions formed in the genome following exposure to many environmentally relevant genotoxins.
Several questions lie at the heart of current studies designed to understand TCR: a) What lesions are subject to it? b) How do such alterations to DNA impede or block the progression of RNA polymerases? c) What is the actual mechanism by which preferential clearance of DNA adducts is achieved, and d) which organisms exhibit the phenomenon? The first question concerns the classes of DNA damage that are cleared preferentially from actively expressed genetic domains and is addressed in Table 1 . This article will focus more on issues b and c-the matter of DNA damage posing blocks to transcription and the mechanism of TCR. Transcriptioncoupled DNA repair in mammalian systems will be emphasized, with studies concerning this type of repair in Escherichia coli being described because of the attributes of this organism that make it a useful model for understanding the process. Spatial constraints do not permit descriptions of TCR in yeast and other important systems; information concerning the process in these organisms can be found in several current texts and reviews (2, 29) . Also, the involvement of DNA repair during organismal development, an important issue due to the high levels of replication and transcription during maturation, will not be addressed (30) .
Neither the precise series of events nor all of the proteins required during TCR CS is characterized by a significant lag time in the recovery of RNA synthesis following exposure of the cells to certain genotoxins, perhaps due to the slow removal of adducts from transcriptionally active regions. Hence, the CS-A and CS-B proteins may act as coupling factors for human TCR or might effect changes in chromatin structure at sites of transcription, enabling these loci to be better repaired (2, 33, 46, 47) .
While the identification of coupling factors that link a stalled transcription complex, DNA damage, and repair machinery has been a great boon to understanding TCR, the precise composition of the repair pathway involved remains to be elucidated. Indeed, the explicit nature of the pathway that elicits TCR is not simple; it appears to involve components of several repair pathways in the cell, each of which may play a distinct role in the process.
The Role ofNudeotide Ecision Repair
Nucleotide excision repair is a repair pathway that removes a wide variety of DNA lesions from the genome; it appears to recognize distortions in the double helix and, therefore, possesses a broad specificity for the types of damage that are cleared by it (2, 4, 6) . In E. coli, where NER is best understood, the actual incision process at the damaged site is a function of the products of the uvrA, uvrB, and uvrCgenes (6). Recognition is accomplished by a protein complex consisting of a UvrA homodimer associated with a UvrB monomerUvrA2-UvrB. Upon adduct recognition, the UvrA proteins dissociate, and UvrC protein binds, creating an exinuclease that incises the damaged strand on either side of the lesion such that during NER a roughly 12-base segment of DNA containing the damage is removed. The product of the uvrD gene, which is helicase II, is essential for the removal of the damaged oligonucleotide and turnover of the UvrB and UvrC proteins (2, 4, 6) .
Numerous mutant strains of E coli exist in which functional NER is absent. Such uvrA-, uvrB-, and uvrC-cells have also been used to investigate the role of NER in TCR in E. coli; in these strains, less than 10% of the CPDs were removed from each strand of the lacZ gene following exposure to UV radiation, indicating that an intact NER complex not only is required for the general removal of CPDs from these cells but also is indispensable for TCR (48) .
The clearance of UV-induced CPDs from mammalian cells by NER is vastly Environmental Health Perspectives * Vol 105, Supplement 1 * February 1997 more complex than the equivalent pathway in E. coli; it is also less well understood. In human cells, at least 30 gene products are required for functional NER to occur; of this number, 7 were identified partly by studying cells derived from patients afflicted with XP, which is characterized by deficient NER and heightened sensitivity to UV radiation (2, 4, 5, 49) . Individuals with XP are prone to a variety of pathological conditions, including skin cancer and neurological aberrations. The seven XP complementation groups are labeled A through G, and each exhibits a different phenotypic sensitivity to UV light. For example, XP-A cells do not repair CPDs and are very sensitive to the lethal effects of UV radiation; in contrast, XP-C cells exhibit a modest level of dimer clearance and are less sensitive to the detrimental effects of UV exposure (49) . A description of some of the genes and the proteins involved in human NER is summarized in Table 2 ; the function of each is also listed when it is known.
TCR has been observed in mammalian cells derived from both rodents and humans, but the features of the process are different in each case (14) (15) (16) . In rodent cells, the clearance of CPDs is manifested as a high level of repair from the transcribed strand of active genes, with virtually no clearance of these lesions from the nontranscribed counterpart (16) . In contrast, human cells exhibit repair in both strands of active genes, albeit the rate of repair is faster in the transcribed strand (16) . In terms of TCR and its relationship to NER, an important issue concerns which of the particular gene products responsible for NER are involved in biased clearance of DNA lesions from human cells. As mentioned, the severest form of XP is manifested in complementation group A. Cells derived from these patients cannot repair CPDs found in the overall Table 2 . Genes and their products involved in NER in humE genome; they also cannot perform TCR of these adducts, indicating that recognition by the XP-A protein of the actual CPD or the helical distortion is necessary for the transcription-coupled clearance of these adducts (50, 59) .
Two of the gene products that take part in NER, the XP-B and XP-D proteins, also participate as elements of transcription factor TFIIH in the cell and possess helicase activity (51, 53, 54, 60) . It is important to understand that these two proteins play a part in NER as part of TFIIH (61) . In other words, TFIIH has a dual function in cells: It acts as a transcription factor and as a component of NER, perhaps by interacting with different sets of proteins in each case. XP-D cells are slightly less sensitive to UV radiation than XP-A cells, and they do remove CPDs to a low but significant extent; however, TCR of these lesions does not occur in most XP-D mutant cells (2, 49, 59 ). This suggests that the TFIIH factor is needed for TCR by participating in NER to clear the lesion; any additional role it plays in the actual coupling process remains to be established. The requirement for the XP-B product in TCR has not yet been evaluated in a cell system, but assuming XP-D protein is involved in biased clearance of adducts via its presence in TFIIH, it could be predicted that XP-B would also be involved. There is an important caveat associated with the study of TCR in XP-B cells: All identified cases of this XP complementation group overlap with CS, which could make the interpretation of the results somewhat difficult (2) .
The role of the XP-C protein in NER and TCR is particularly intriguing. XP-C cells are more resistant to the detrimental effects of UV radiation than XP-A, XP-B, and XP-D cells; they also repair CPDs to a small but significant extent (2, 49 (57) aThe ERCC genes were identified as those human genes that complemented NER defects in mutant rodent cells; indeed, ERCC is an abbreviation for excision repair cross-complementing. The genes that are labeled as XP-A and so on are those that were discovered by transfecting human DNA into cells belonging to differing XPcomplementation groups. There is also an ERCC1 gene whose product does not correct any of the XP phenotypes (58 (2) .
The XP-F protein, in association with ERCC1, and XP-G protein are responsible for incising the DNA on the 5' and 3' sides of the lesion, respectively, causing the release of a roughly 29-base fragment of DNA containing the damage (2,4,6,56,57). TCR of CPDs requires the XP-F product; however, the need for XP-G protein has not yet been examined (59) . These results suggest that the actual incision of the damaged DNA during TCR of CPDs requires the same endonucleolytic proteins used during NER of CPDs.
In summary, then, functional NER is necessary for the TCR of CPDs in both bacteria and mammalian cells. Furthermore, studies concerning the specific repertoire of NER proteins in human cells needed for TCR indicate that XP-A, XP-D, and XP-F gene products are required; the remaining NER proteins might also be necessary, but direct experimental data proving this assertion are not yet available. Perhaps the most curious of all the XP proteins in terms of TCR is the XP-C gene product; cells that lack this gene product can perform TCR but cannot execute general NER in quiescent regions of the genome.
A final critical issue that needs to be addressed in terms of TCR is related to the ability to clear chemical adducts in a biased fashion via NER. As illustrated in Table 1 (2, 7, 8) .
There are numerous examples of DNA damage that is repaired by BER, two of which include N-alkylpurines and thymine glycols. The former are removed by 3- alkyladenine-DNA glycosylase, and the latter are cleared by thymine glycol-DNA glycosylase (2, 7, 8) . As mentioned, the subsequent endonucleolytic cleavage is sometimes associated with the glycosylase activity, as is the case for thymine glycol-DNA glycosylase, or it can be independent of the base removal step, as is true for 3-alkyladenine-DNA glycosylase. An important issue concerning TCR is whether glycosylase-mediated clearance of damage exhibits a more rapid repair that is associated with the transcribed strand of active genes. Evidence suggesting that this is the case has been reported (22) . It (25, 26, 66) . Furthermore, when 7-methylguanine and 3-methyladenine repair rates are determined individually for each of the strands of the dhfr gene, no TCR is observed in either case. This is an important observation because 3-methyladenine impedes transcription; hence, these data indicate that an interruption to RNA synthesis is not the sole factor responsible for summoning TCR (26) . Interestingly, the clearance of N-ethylpurines shows a strong bias toward the transcribed strand of the dhfr gene in cells where NER is intact; this preferential clearance is not seen in cells lacking functional NER, where the observed repair is presumably executed by BER. These results indicate that BER is not coupled to TCR, at least in the case of ethylated purines (Sitaram et al., unpublished observations). Clearly, there would be benefits from investigating N-alkylpurine repair in cells lacking the 3-alkyladenine-DNA glycosylase; homozygous mutant mouse cells have recently been characterized that lack this activity, which now makes such experiments feasible (67) .
Several possible explanations for the contrasting data concerning the preferential clearance of thymine glycols and N-methylpurines by BER can be devised. These two glycosylases are quite different, not only in terms of substrate recognition but because thymine glycol-DNA glycosylase actually contains an associated abasic endonuclease activity, whereas 3-alkyladenine-DNA glycosylase does not possess such a feature. There is the possibility that the thymine glycol glycosylase is coupled to transcription, but 3-alkyladenine-DNA glycosylase is not part of TCR. A second possible source of the difference could lie in the fact that thymine glycols are substrates for both NER and BER in eukaryotic cells, whereas N-methylpurines are cleared primarily by BER (6); however, this does not account for the N-ethylpurine data. A third viable explanation might be that thymine glycols are blocks to transcription, a fact that would make them subject to TCR; in contrast, 7-methylguanines, which constitute 80% of the N-methylpurines, do not appear to inhibit transcription and would not be predicted to be removed in a transcription-coupled fashion.
While the data concerning BERmediated TCR appear to be somewhat contradictory, it is important to realize that preferential DNA repair depends on several factors: the type of damage, its location in the genome, and its ability to block RNA synthesis. A true understanding of the TCR pathway can only be obtained by considering the clearance of a variety of different adducts from specific loci in cells exhibiting different repair phenotypes. Indeed, in a somewhat unexpected way, the picture has been made even more complex by the discovery that mismatch recognition proteins comprise a pivotal element of TCR (48) .
The Role ofMismatch Repair
The genetics and biochemistry of methyldirected MMR have been extensively characterized in E. coli (2, 9, 68 misincorporation into the nascent transcript can facilitate pausing of RNA polymerase. In general, then, the first stage required for TCR, stalling of the RNA polymerase, is in and of itself affected by a complex array of factors, many of which still require further clarification of their particular roles in the process.
Once the RNA polymerase has stalled, CS-A, CS-B, and mismatch recognition proteins may enter the pathway. Precisely how these factors interact with DNA at or near the site of damage present on the transcribed strand remains unclear. At least two conceivable scenarios can be devised regarding the role of these proteins in TCR, both of which rely on the notion that they somehow convert the damaged site into a better substrate for repair enzymes. One possibility is that the CS-A and CS-B factors first displace the RNA polymerase in a manner equivalent to that of the Mfd protein in E. coli, making the lesion more available for recognition by the MMR proteins; this particular model relies on the prospect that the recognition system for MMR can also sense abnormal bases present in DNA, an event that has been documented for several DNA lesions (72, 73) . A second model involves the possibility that interactions among the CS-A, CS-B, and mismatch proteins change the supercoiled nature of the DNA at the adduct site, making the region better for recognition by repair proteins. Regardless of which of these models is correct-in reality, both may be proven to be incorrect-much biochemistry will need to be performed to test these prospects.
The final step in TCR concerns the precise nature of the repair pathway that ultimately clears the damage; as of now, either NER or BER participates in the process. While NER, BER, and MMR have been shown in part to effect TCR, the potential role of direct reversal repair pathways has yet to be elucidated. With regard to the repair machinery involved in TCR, more studies concerning the clearance of damage from cells with varying repair backgrounds is essential, particularly as mutants in BER become available. Also, the size of the repair patch following the TCR of a lesion from the transcribed strand of an expressed gene has not been established; hence no information concerning the involvement of long-patch versus shortpatch repair can be used to support or refute any proposed mechanisms underlying TCR Clearly, the general rules concerning TCR will emerge fully only after studies addressing these issues have been conducted.
It is clear that TCR operates on numerous types of DNA damage that can be induced in organisms by a wide range of environmental agents; indeed, it is becoming increasingly apparent that biased mutagenesis within genes can occur following exposure to chemicals and radiation, and it may well be a consequence of TCR at work (2, 3) . Because mutations in the genome of a cell can lead to transformation or death, an understanding of mechanisms that modulate cell formation of mutations is critical for comprehending how environmental carcinogens exert their toxic effects on an organism.
